I en kontrolleret dobbeltblind klinisk undersøgelse af 2 års varighed forsinkede initial behandling med pramipexol signifikant fremkomsten af motoriske komplikationer og reducerede deres forekomst sammenlignet med initial behandling med levodopa.
In a controlled double blind clinical trial of 2 year duration, initial treatment with pramipexole significantly delayed the onset of motor complications, and reduced their occurrence compared to initial treatment with levodopa.